200 related articles for article (PubMed ID: 27285161)
1. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
[TBL] [Abstract][Full Text] [Related]
3. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
[TBL] [Abstract][Full Text] [Related]
4. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
[TBL] [Abstract][Full Text] [Related]
5. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
[TBL] [Abstract][Full Text] [Related]
6. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
[TBL] [Abstract][Full Text] [Related]
8. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer.
Azahaf M; Haberlay M; Betrouni N; Ernst O; Behal H; Duhamel A; Ouzzane A; Puech P
J Magn Reson Imaging; 2016 Mar; 43(3):737-49. PubMed ID: 26303794
[TBL] [Abstract][Full Text] [Related]
9. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
10. Improving the arterial input function in dynamic contrast enhanced MRI by fitting the signal in the complex plane.
Simonis FF; Sbrizzi A; Beld E; Lagendijk JJ; van den Berg CA
Magn Reson Med; 2016 Oct; 76(4):1236-45. PubMed ID: 26525012
[TBL] [Abstract][Full Text] [Related]
11. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer.
Fan X; Chatterjee A; Pittman JM; Yousuf A; Antic T; Karczmar GS; Oto A
Acad Radiol; 2022 Jun; 29(6):796-803. PubMed ID: 34583866
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of prostate cancer using independent component analysis.
Mehrabian H; Da Rosa M; Haider MA; Martel AL
Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
[TBL] [Abstract][Full Text] [Related]
15. Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer.
Ziayee F; Mueller-Lutz A; Gross J; Ullrich T; Quentin M; Arsov C; Antoch G; Wittsack HJ; Schimmöller L
Diagn Interv Radiol; 2022 Mar; 28(2):108-114. PubMed ID: 35548894
[TBL] [Abstract][Full Text] [Related]
16. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW
Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135
[TBL] [Abstract][Full Text] [Related]
17. Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
Nadav G; Liberman G; Artzi M; Kiryati N; Bashat DB
J Magn Reson Imaging; 2017 Jan; 45(1):237-249. PubMed ID: 27383624
[TBL] [Abstract][Full Text] [Related]
18. Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images.
Sanz-Requena R; Prats-Montalbán JM; Martí-Bonmatí L; Alberich-Bayarri Á; García-Martí G; Pérez R; Ferrer A
J Magn Reson Imaging; 2015 Aug; 42(2):477-87. PubMed ID: 25410482
[TBL] [Abstract][Full Text] [Related]
19. Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues.
Wang S; Fan X; Medved M; Pineda FD; Yousuf A; Oto A; Karczmar GS
Magn Reson Imaging; 2016 Feb; 34(2):197-203. PubMed ID: 26523650
[TBL] [Abstract][Full Text] [Related]
20. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]